Vastra Frolunda, Sweden

Gunnar Ohlin

This inventor holds 3 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignee: Carmel Pharma Ab. Active years: 2016-2018.


% Patents Active = 100.0


 

Average Co-Inventor Count = 1.5

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2016-2018

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Gunnar Ohlin

Introduction

Gunnar Ohlin is a notable inventor based in Västra Frölunda, Sweden. He has made significant contributions to the field of medical devices, holding a total of three patents. His work focuses on enhancing the functionality and safety of medical equipment.

Latest Patents

Gunnar Ohlin's latest patents include a protective cap designed for medical devices such as vials. This protective cap features a membrane holder that securely mounts a resilient membrane. The membrane includes both a piercing portion and a sealing portion, ensuring a reliable seal when applied to the medical device. Another significant patent is the sealing barrier arrangement, which provides a liquid-tight seal between a piercing member and a barrier member. This invention also includes methods for connecting medical devices, enhancing their security and prolonging their working life.

Career Highlights

Gunnar Ohlin is associated with Carmel Pharma AB, where he continues to innovate in the medical device sector. His work has been instrumental in developing solutions that improve patient safety and device reliability.

Collaborations

Gunnar collaborates with Fredrik Bäckström, contributing to the advancement of medical technology through their combined expertise.

Conclusion

Gunnar Ohlin's contributions to medical device innovation demonstrate his commitment to improving healthcare solutions. His patents reflect a deep understanding of the needs within the medical field, ensuring safer and more effective devices for users.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…